Cameco Corp. Stock
€65.52
Your prediction
Cameco Corp. Stock
Pros and Cons of Cameco Corp. in the next few years
Pros
Cons
Performance of Cameco Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cameco Corp. | -0.970% | 1.471% | 3.934% | 77.369% | 31.303% | 128.173% | 576.021% |
| enCcore Energy Corp. | -1.480% | 1.320% | -9.318% | -39.325% | -39.399% | -38.140% | - |
| Forsys Metals Corp. | 4.140% | 3.864% | 1.053% | -10.757% | -12.953% | -37.662% | 231.034% |
| Azarga Metals Corp. | - | 16.393% | -12.346% | 545.455% | 195.833% | -11.250% | -85.510% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When examining the financials of Cameco Corporation (US symbol: CCJ), which operates in the uranium industry, a nuanced picture emerges. The company’s financial statements indicate healthy revenue generation but also present challenges, particularly regarding profitability margins and significant debt levels. As a leader in uranium production, Cameco is well-positioned in a sector that is increasingly gaining attention due to renewed interest in nuclear energy. However, as any thorough analysis will reveal, the implications of the financial ratios require a closer look.
Strong Revenue Base: Cameco has reported a total revenue of CAD 2.59 billion for 2023, indicating solid operational performance. The revenue generation reflects the company's robust demand and market position within the uranium sector, which is attractive for growth potential.
Positive EBITDA Figures: The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stands at CAD 502 million. This figure underscores the operational efficiency of Cameco, suggesting that the company can generate substantial earnings from its core activities. A healthy EBITDA is often viewed as an indicator of a firm's profitability before non-operational expenses are factored in.
Comments
News
Is Cameco Stock a Buy Now?
Nuclear energy is experiencing a resurgence, and Cameco (NYSE: CCJ) is well positioned for the renewed interest. Since the beginning of the year, the stock has surged by 46%, fueled by a wave of
Why Cameco Stock Popped Today
Shares of Cameco (NYSE: CCJ), a Canadian uranium mining company, jumped 3.9% through noon ET on Friday -- and the reason is anybody's guess.
That's not to say there's no reason for Cameco stock to
This No-Brainer Nuclear Stock Is a Screaming Buy With Just $100
Cameco (NYSE: CCJ) controls some of the world's richest uranium resources and is expanding into reactor technology just as AI's massive power needs ignite nuclear demand. With a global supply